Identifying opportunities to improve medication management in transitions of care.

Am J Health Syst Pharm

Jessica M. Downes, Pharm.D., BCACP, is Clinical Assistant Professor, Department of Pharmacy Practice, University of Nebraska Medical Center, Omaha, and Clinical Pharmacist, One-World Community Health Center, Omaha; at the time of writing, she was Postgraduate Year 2 Pharmacy Resident, University of Oklahoma (OU) College of Pharmacy-Tulsa. Katherine S. O'Neal, Pharm.D., M.B.A., BCACP, CDE, BC-ADM, AE-C, is Assistant Professor, Department of Pharmacy: Clinical and Administrative Sciences, OU College of Pharmacy-Tulsa and Department of Pediatrics, OU School of Community Medicine-Tulsa. Michael J. Miller, B.S.Pharm., Dr.P.H., FAPha, is Associate Professor; and Jeremy L. Johnson, Pharm.D., BCACP, CDE, BC-ADM, is Assistant Professor, Department of Pharmacy Practice, Southwestern Oklahoma State University College of Pharmacy, Weatherford. Brooke L. Gildon, Pharm.D., BCPS, AE-C, is Assistant Professor, Department of Pharmacy: Clinical and Administrative Sciences, OU College of Pharmacy-Tulsa and Department of Pediatrics, OU School of Community Medicine-Tulsa. Michael A. Weisz, M.D., MACP, is Professor, Department of Internal Medicine, OU School of Community Medicine-Tulsa.

Published: September 2015

Purpose: The types and causes of medication discrepancies during the transition from inpatient to ambulatory care were investigated.

Methods: A descriptive study was conducted at an academic outpatient group practice affiliated with a private nonacademic hospital to (1) describe discrepancies between inpatient discharge summaries and patient-reported medication lists, (2) identify patient and system factors related to breakdowns in medication documentation, and (3) determine reasons for medication discrepancies. During a four-month period, 17 patients at high risk for medication misadventures while transitioning from hospital care to outpatient follow-up were contacted by telephone soon after discharge and asked to provide information on all medications they were taking. Patient-reported medication lists were compared with the corresponding discharge summaries, and medication discrepancies were categorized by patient- and system-level factors using a validated instrument.

Results: Of the total of 96 discrepancies identified, more than two thirds (n = 67, 68%) involved the omission of a prescribed medication from either the patient-reported list or the discharge summary. Cardiovascular medications, including antihypertensives, antilipemics, diuretics, and antiarrhythmics, accounted for almost one quarter of all medication discrepancies. About 15% (n = 14) and 16% (n = 15) of identified discrepancies related to medication dose and frequency, respectively.

Conclusion: Among 17 patients transitioning from inpatient to outpatient care, nearly 100 discrepancies between patient-reported medication lists and discharge summaries were identified. Most discrepancies were attributed to nonintentional nonadherence and resumption of home medications without instructions to do so. All 17 patients had at least 1 medication discrepancy categorized as involving a system-level factor.

Download full-text PDF

Source
http://dx.doi.org/10.2146/ajhp150059DOI Listing

Publication Analysis

Top Keywords

medication discrepancies
16
medication
13
discharge summaries
12
patient-reported medication
12
medication lists
12
discrepancies
9
identified discrepancies
8
discharge
5
identifying opportunities
4
opportunities improve
4

Similar Publications

Purpose: Congenital pseudarthrosis of the tibia (CPT) is a rare condition typically manifesting within the first decade of life. The primary objectives of surgical intervention for CPT include achieving long-term bony union of the tibia, preventing or minimizing limb length discrepancies (LLD), avoiding mechanical axis deviations of the tibia and adjacent joints, and preventing refracture. This study aims to conduct a systematic review of current treatment methods for CPT to determine the most effective non-surgical and surgical management strategies for pediatric patients with this condition.

View Article and Find Full Text PDF

Background: The accuracy of Logical Observation Identifiers Names and Codes (LOINC) mappings is reportedly low, and the LOINC codes used for research purposes in Korea have not been validated for accuracy or usability. Our study aimed to evaluate the discrepancies and similarities in interoperability using existing LOINC mappings in actual patient care settings.

Methods: We collected data on local test codes and their corresponding LOINC mappings from seven university hospitals.

View Article and Find Full Text PDF

The progression of Alzheimer's disease (AD) is intricately tied to the impairment of neurons, crucial for neurological functions. Despite extensive research, the precise mechanism underlying AD development remains elusive due to its multifaceted aetiology. Vitamin deficiency has emerged as a notable contributor to AD onset and progression, exerting a significant influence on brain function.

View Article and Find Full Text PDF

Background: The success of selecting high risk or early-stage Alzheimer's disease individuals for the delivery of clinical trials depends on the design and the appropriate recruitment of participants. Polygenic risk scores (PRS) show potential for identifying individuals at risk for Alzheimer's disease (AD). Our study comprehensively examines AD PRS utility using various methods and models.

View Article and Find Full Text PDF

mRNA vaccines in the context of cancer treatment: from concept to application.

J Transl Med

January 2025

Department of Biochemistry and Molecular Biology, Binzhou Medical University, 346 Guanhai Road, Yantai, 264003, P. R. China.

Immuno-oncology has witnessed remarkable advancements in the past decade, revolutionizing the landscape of cancer therapeutics in an encouraging manner. Among the diverse immunotherapy strategies, mRNA vaccines have ushered in a new era for the therapeutic management of malignant diseases, primarily due to their impressive impact on the COVID-19 pandemic. In this comprehensive review, we offer a systematic overview of mRNA vaccines, focusing on the optimization of structural design, the crucial role of delivery materials, and the administration route.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!